AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
61 hedge funds and large institutions have $61.4M invested in Agile Therapeutics in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $68.1M → $61.4M (-$6.6M)
Holders
61
Holding in Top 10
1
Calls
$1.03M
Puts
$294K
Top Buyers
| 1 | +$7.44M | |
| 2 | +$2.38M | |
| 3 | +$2.23M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$930K |
Top Sellers
| 1 | -$4.23M | |
| 2 | -$2.22M | |
| 3 | -$819K | |
| 4 |
EP
Eversept Partners
New York
|
-$788K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$225K |